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Abstract Halohydrin dehalogenases are industrially relevant
enzymes that catalyze the reversible dehalogenation of vicinal
haloalcohols with formation of the corresponding epoxides. In
the reverse reaction, also other negatively charged nucleo-
philes such as azide, cyanide, or nitrite are accepted besides
halides to open the epoxide ring. Thus, novel C-N, C-C, or C-
O bonds can be formed by halohydrin dehalogenases, which
makes them attractive biocatalysts for the production of vari-
ous β-substituted alcohols. Despite the fact that only five in-
dividual halohydrin dehalogenase enzyme sequences have
been known until recently enabling their heterologous produc-
tion, a large number of different biocatalytic applications have
been reported using these enzymes. The recent characteriza-
tion of specific sequence motifs has facilitated the identifica-
tion of novel halohydrin dehalogenase sequences available in
public databases and has largely increased the number of
recombinantly available enzymes. These will help to extend
the biocatalytic repertoire of this enzyme family and to foster
novel biotechnological applications and developments in the
future. This review gives a general overview on the halohy-
drin dehalogenase enzyme family and their biochemical prop-
erties and further focuses on recent developments in halohy-
drin dehalogenase biocatalysis and protein engineering.
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Introduction
In 1968, Castro and Bartnicki reported for the first time an
enzyme from Flavobacterium sp. involved in the degradation
of 2,3-dibromo-1-propanol by removal of the bromo-
substituent in 2-position and concomitant formation of the
corresponding epoxide epibromohydrin (Castro and
Bartnicki 1968). The enzyme was then termed halohydrin
epoxidase and is member of a diverse group of dehalogenases
(Janssen 2007). Since then, a number of enzymes able to
dehalogenate various vicinal halohydrins have been isolated
from different bacterial species and have been characterized
for their biochemical and biocatalytic properties. These en-
zymes, also called halohydrin dehalogenases (HHDHs),
haloalcohol dehalogenases, or halohydrin hydrogen-halide-ly-
ases, belong to the enzyme class of lyases (EC 4.5.1.-) and
catalyze the reversible dehalogenation of halohydrins with
epoxide formation through intramolecular nucleophilic dis-
placement of the halogen substituent by the neighboring hy-
droxyl group (Fig. 1). In addition, the enzymes can also utilize
other negatively charged nucleophiles such as cyanide, azide,
or nitrite in an irreversible epoxide ring opening reaction,
resulting in the formation of novel C-C, C-N, or C-O bonds
(Fig. 1; Hasnaoui-Dijoux et al. 2008). This reaction and nu-
cleophile promiscuity of HHDHs, enabling the biocatalytic
formation of various epoxides and β-substituted alcohols,
makes them attractive candidates for practical application in
biocatalysis.
Despite the rather large number of studies dealing with the
isolation of microbial strains that exhibit HHDH activity and
purification of the respective enzymes, only very few of the
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corresponding HHDH-encoding genes have been cloned. For
that reason, until recently, only five different HHDH sequences
have been published and assigned to one of the three different
phylogenetic subtypes A, B, andC: hheA fromCorynebacterium
sp. strain N-1074 (Yu et al. 1994), hheA2 from Arthrobacter sp.
strain AD2 (van Hylckama Vlieg et al. 2001), hheB from
Corynebacterium sp. strain N-1074 (Yu et al. 1994), hheB2 from
Mycobacterium sp. strain GP1 (vanHylckamaVlieg et al. 2001),
and two identical hheC sequences from Agrobacterium
radiobacter AD1 (van Hylckama Vlieg et al. 2001) and
Rhizobium sp. strain NHG3 (Higgins et al. 2005). Of these,
HheC from A. radiobacter AD1 has been studied the most as
this enzyme seems to be an exception due to its remarkable
(enantio)selectivity (Koopmeiners et al. 2016).
Naturally, these and other dehalogenases are reported to be
involved in the mineralization of halogenated compounds
(Janssen et al. 2005). Interestingly, however, only two of the
HHDH genes known today are part of an operon together with
an epoxide hydrolase required for further metabolization of
the epoxide formed during HHDH catalysis (Schallmey
et al. 2014). Hence, it cannot be excluded that halohydrin
dehalogenases might exhibit also other physiological
functions.
Structural and mechanistic aspects
Phylogenetically, HHDHs belong to the superfamily of short-
chain dehydrogenases/reductases (SDRs), with which they
share several structural and mechanistic features (van
Hylckama Vlieg et al. 2001; Kavanagh et al. 2008). HHDHs
are homotetramers, formed by a pair of dimers, and possess a
catalytic triad made of Ser-Tyr-Arg similar to the Ser-Tyr-Lys
catalytic triad of many SDR enzymes. Instead of the nicotin-
amide cofactor binding site found in SDR enzymes, a spa-
cious nucleophile binding pocket is present at a corresponding
position in HHDHs. To date, the crystal structures of HheA
(Watanabe et al. 2015), HheA2 (de Jong et al. 2006), HheB
(Watanabe et al. 2015), and HheC (de Jong et al. 2003) have
been solved and reveal an overall highly similar structural
fold. The monomers exhibit the typical Rossmann fold, also
found for other SDR enzymes, consisting of a six- or seven-
stranded parallel β-sheet that is surrounded by seven or
eight α-helices (Fig. 2a). Each monomer’s active site is
buried within the enzyme and is connected with the bulk
solvent via a substrate entrance tunnel. This tunnel is dif-
ferently shaped in the crystallized HHDHs and —at least
for HheC— various studies demonstrate that residues of the
entrance tunnel are involved in determining the enzymes’
activity and enantioselectivity (Schallmey et al. 2013; Guo
et al. 2015; Wang et al. 2015b). The position of the catalytic
residues Ser, Tyr, and Arg within the active sites is also
highly conserved. During dehalogenation, the Ser residue
positions the haloalcohol substrate within the active site by
formation of a hydrogen bond with the substrate’s hydroxyl
group, while the Tyr acts as a catalytic base abstracting a
proton from that hydroxyl group (Fig. 3). The Arg residue
does not interact with the substrate itself but lowers the pKa
of the tyrosine-OH via hydrogen bonding in order to acti-
vate it for proton abstraction (de Jong et al. 2003; Janssen
et al. 2006; Schallmey et al. 2012). In the reverse reaction,
i.e., epoxide ring opening, the Tyr donates a proton to the
forming oxygen anion after nucleophilic attack of a halide
(or another accepted nucleophile) on one of the carbons of
the epoxide ring. The nucleophile binding pocket in
HHDHs is formed by residues mapping to the glycine-
rich T-G-X3-A/G-X-G motif of SDR enzymes as well as
residues from other loops forming hydrogen bonds from
backbone amides with the anionic nucleophile (de Jong
et al. 2003). Additionally, a water molecule present in close
proximity supports the hydrogen bond network around the
nucleophile binding pocket.
Fig. 1 Catalytic scope of
halohydrin dehalogenases in
dehalogenation and epoxide ring
opening
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Interestingly, only HheC possesses a C-terminal extension
which protrudes into the active site of an opposing monomer
within the tetrameric quaternary assembly. This C-terminal
extension contains a Trp residue (Trp249; Fig. 2d), which
Fig. 3 Catalytic mechanism of
halohydrin dehalogenases in
dehalogenation and epoxide ring
opening; residue numbering
according to HheC
Fig. 2 Structural aspects of
halohydrin dehalogenases, a
overall structure and tetrameric
assembly of HheC as well as
active-site structure of b HheA2
(PDB 1ZMO), c HheB (PDB
4ZD6), and d HheC (PDB
1ZMT). Water molecules in the
nucleophile binding sites of
HheA2 and HheC are shown as
red sphere; the chloride ion in the
active site of HheB is given as
green sphere
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significantly influences the stereoselectivity of HheC (Tang
et al. 2003; de Jong et al. 2005).
Enzyme family
For a long time, the previously cloned enzymes—HheA/A2,
HheB/B2, or HheC— were the only representatives of the
HHDH enzyme family. All these enzymes were obtained from
bacterial strains enriched from environmental samples to de-
grade toxic compounds such as epihalohydrins or
haloalcohols as sole carbon source (van den Wijngaard et al.
1989; Poelarends et al. 1999; Effendi et al. 2000) and some-
times yielded optically active C3 compounds (Nakamura et al.
1991). Although these individual bacterial strains were
enriched from three different global sampling sites, the actual
HHDH sequence identities were larger than 97% for enzymes
of the same HHDH subtype (Yu et al. 1994; van Hylckama
Vlieg et al. 2001; Higgins et al. 2005). Further, using HHDH-
specific oligonucleotides, only HHDHs with either 97 or
100 % enzyme sequence identity to HheA or HheC, respec-
tively, could be obtained in recombinant form from related
bacterial strains (Liu et al. 2014; Xue et al. 2014).
Alternatively, public sequence databases are a common source
for novel enzyme sequences, but direct identification of novel
HHDHs via homology searches is hampered due to their ac-
tual high similarity to non-dehalogenating SDR enzymes. Due
to sequence identities lower than 33% between A-, B-, and C-
type enzymes, conventional BLAST searches with any of the
earlier described HHDHs as query commonly return better
ranking SDR sequences before listing putative novel HHDH
sequences. While it might be a viable option to recombinantly
express and assay candidate sequences for true HHDH activ-
ity when only few other better ranking SDR hits exist in
BLAST results (Wan et al. 2014), such experimental strategies
are not practical for distantly related sequences with hundreds
or thousands of possible candidate genes. To unambiguously
identify true HHDHs from the large majority of SDR enzymes
present in databases such as GenBank, HHDH-specific se-
quence motifs were recently derived from multiple sequence
alignments of the known HHDHs to filter for candidate se-
quences with only target activity (Schallmey et al. 2014).
Here, the combination of an N-terminal motif as part of the
nucleophile binding pocket architecture (T-X4-F/Y-X-G) and
a second motif resembling the HHDH catalytic triad (S-X12-
Y-X3-R) was very effective to successfully identify 37 novel
HHDH genes by PHI-BLAST. For a representative and di-
verse selection of 19 enzymes, true HHDH activity was con-
firmed after heterologous expression, illustrating the useful-
ness of this in silico identification strategy. Phylogenetic anal-
ysis revealed that several of these novel HHDHs could not be
assigned to any of the previously classified subtypes A to C
and thus required grouping within four additional subtypes D
through G. Apparently, when characterizing 17 of these en-
zymes in more detail (Koopmeiners et al. 2016), this phylo-
genetic classification scheme seems to be largely in agreement
with biocatalytic properties such as enantioselectivities.
Although most of the selected 17 novel HHDHs exhibit only
low sequence identities to previously known HHDHs, their
biochemical and biocatalytic properties are still rather similar.
Among these enzymes, only HheA3, HheA5, HheD, HheD3,
and HheD5 stand out because they display higher thermosta-
bilities and temperature optima in comparison to HheC.
Enzymes HheA3 (Wan et al. 2014) and HheA5 (Xue et al.
2015a) from Parvibaculum lavamentivorans DS-1 and
Tistrella mobilis, respectively, have been characterized by
Zheng and coworkers as well. The authors reported a higher
thermostability for HheA5 too as well as a high activity in the
cascade-type conversion of ethyl (S)-4-chloro-3-
hydroxybutyrate into ethyl (R)-4-cyano-3-hydroxybutyrate.
Additionally, researchers around Zheng cloned and confirmed
HHDH activity for an enzyme from Agromyces mediolanus
(HheA12; Xue et al. 2014), an enzyme with 98 % sequence
identity to previously known HheA4 (Schallmey et al. 2014).
Applying both HHDH-specific sequence motifs in PHI-
BLAST queries on the recent GenBank release (version
213), another 26 enzyme sequences can be identified belong-
ing to one of the currently classified HHDH subfamilies and,
thus, extend the growing list of HHDH enzymes (Table S1).
Phylogenetically, most of these putative enzymes are either A-
or D-subtype HHDHs (Fig. 4). Enzymes HheA10 and
HheA13 through HheA15 are 27–42 % identical to HHDHs
for which activity has been confirmed, including HheA11
(unpublished data) and HheA12 (Xue et al. 2014). In contrast
to the more diverse branch of the A/C-type enzymes, HheD19
to HheD38 exhibit 57 to 95 % sequence identities to experi-
mentally verified HHDHs HheD through HheD6.
Biocatalytic applications
Various biotechnological applications, especially regarding
stereoselective biotransformations, have been described using
halohydrin dehalogenases. The most important one is certainly
the production of the statin side-chain precursor ethyl (R)-4-
cyano-3-hydroxybutyrate from ethyl (S)-4-chloro-3-
hydroxybutyrate via the corresponding (S)-epoxide as interme-
diate (Fig. 5). This biocatalytic process starts from prochiral
ethyl 4-chloroacetoacetate, which is selectively reduced by an
(S)-selective ketoreductase affording ethyl (S)-4-chloro-3-
hydroxybutyrate (Ma et al. 2010). The latter is further converted
by a heavily engineered HheC mutant generated by ProSAR-
based protein engineering tomeet specific process requirements
such as high cyanolysis activity or increased enzyme stability
(Fox et al. 2007). Further biocatalytic applications of HHDHs
include the synthesis of other enantiopure C3 or C4 units, such
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as epihalohydrins (Lutje Spelberg et al. 2004), or chiral tertiary
alcohols (Majeric Elenkov et al. 2007; Fuchs et al. 2009).
Besides that, several reports describe the use of HHDHs for
the biodegradation of toxic xenobiotics such as 1,2,3-
trichloropropanol present in contaminated soil and water
(Dvorak et al. 2014) or the removal of 3-chloro-1,2-propanediol
esters formed during food processing (Bornscheuer and
Hesseler 2010). Very recently, also, the application of a halohy-
drin dehalogenase for the quantification of azide and cyanide in
aqueous solution was reported (Wan et al. 2015c). The method
is based on the HHDH-catalyzed reaction of azide or cyanide
with 1,2-epoxybutane and detection of the resulting products 1-
azidobutan-2-ol and 3-hydroxypentanenitrile, respectively, by
gas chromatography.
Since surveying the HHDH literature in 2012, a number of
papers on biocatalytic applications of HHDHs have been pub-
lished. Only few of them, however, indeed present novel ap-
plications or synthetic routes toward new products. For a more
complete picture, especially including earlier applications of
HHDHs in biocatalysis and biotechnology in general, the
reader is also referred to previous reviews (Janssen et al.
2006; Schallmey et al. 2012; You et al. 2012).
Chiral C3/C4 units
Since the first synthesis of ethyl (R)-4-cyano-3-hydroxybutyrate,
a precursor of atorvastatin, from ethyl-4-chloroacetoacetate by
combination of an (S)-selective ketoreductase and an HheC
Fig. 4 Phylogenetic
representation of the extended
HHDH enzyme family. The
shown phylogram is constructed
from a maximum likelihood built
with W-IQ-TREE (Trifinopoulos
et al. 2016) on the basis of a
PRANK +F (Löytynoja and
Goldman 2010) multiple
sequence alignment of all
HHDHs from Table S1.
Experimentally verified HHDH
sequences are marked by an
asterisk
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mutant (Fig. 5; Fox et al. 2007), several recent biocatalytic stud-
ies on HHDHs have focused on the production of ethyl (R)-4-
cyano-3-hydroxybutyrate. Wan et al. (2014) successfully ap-
plied HheA3 from P. lavamentivorans DS-1 in the preparative-
scale synthesis of ethyl (R)-4-cyano-3-hydroxybutyrate starting
from 200 g L−1 ethyl (S)-4-chloro-3-hydroxybutyrate using a
whole-cell biocatalytic system. Within 14 h, 95 % conversion
and 85 % yield could be reached, however, still employing a
rather high catalyst loading (40-g L−1 lyophilized cells). An
alternative route toward ethyl (R)-4-cyano-3-hydroxybutyrate
proceeds via (S)-4-chloro-3-hydroxybutyronitrile (Fig. 5).
Hence, production of (S)-4-chloro-3-hydroxybutyronitrile from
cheap 1,3-dichloropropan-2-ol by HHDH catalysis was also in-
vestigated. This reaction proceeds via dehalogenation of the
prochiral substrate and subsequent ring opening of the
formed epoxide epichlorohydrin using cyanide as the
nucleophile. Wan et al. (2015b) tested different HHDHs in this
reaction and found that only HheC gave the desired (S)-4-
chloro-3-hydroxybutyronitrile with sufficient enantiomeric ex-
cess. Here, stereoselectivity is introduced in the second reac-
tion step as HheC preferentially converts (S)-epichlorohydrin
to the corresponding butyronitrile. In the past, this high (S)-
enantioselectivity of HheC has been already observed during
azidolysis of epichlorohydrin (Lutje Spelberg et al. 2004).
Now, by applying the more selective mutant HheC W249F,
product ee could be further increased to >99 %. When scaling
up the reaction to 200mL, (S)-4-chloro-3-hydroxybutyronitrile
was obtained in 86 % yield from 20 mM 1,3-dichloropropan-
2-ol within 1 h, while the product ee decreased only slightly to
97.5 %.
Epichlorohydrin and other epihalohydrins are important in-
termediates in the preparation of polymers, adhesives, or phar-
maceuticals and—especially for the latter— enantiomerically
pure epihalohydrins are required (Kasai et al. 1998). Kinetic
resolution of racemic epichlorohydrin by nitrite-mediated ep-
oxide ring opening using HheC afforded (R)-epichlorohydrin
with 99 % ee at 41 % conversion after only 18 min (Jin et al.
2012). Longer incubation times resulted in full conversion of
the racemic epoxide as also the (R)-enantiomer is accepted by
HheC, however, at a lower rate. Likewise, the authors investi-
gated the one-pot, two-step synthesis of (R)-epichlorohydrin
starting from prochiral 1,3-dichloropropan-2-ol. In this reac-
tion, dehalogenation of 1,3-dichloropropan-2-ol and epoxide
ring opening of the resulting epichlorohydrin were carried out
in two sequential steps in order to adjust the reaction conditions
to optimal pH and temperature in between. This was required
to yield (R)-epichlorohydrin in high (99 %) enantiomeric ex-
cess, although yield (25% starting from the chloroalcohol) was
still low. In another approach, Jin et al. (2013) were able to
synthesize (R)-epichlorohydrin with an ee of 99 % by combin-
ing HheC with an epoxide hydrolase in a two-phase reaction
system.
Besides that, Zheng and coworkers published several pa-
pers dealing with the production of epichlorohydrin, either
racemic or enantiomerically pure, as well as (S)-2,3-
dichloro-1-propanol by HHDH catalysis, applying different
process optimization strategies such as in situ product remov-
al, catalyst immobilization, and/or organic-aqueous two-phase
systems (Zou et al. 2013; Zou et al. 2014).
Cascade reactions
In the last years, biocatalytic cascade reactions have emerged
as powerful tool for the synthesis of various products. By
combination of different enzymatic reaction steps in one pot
and in analogy to catalysis performed in nature, intermediate
Fig. 5 Biocatalytic synthesis of statin side-chain precursors
7832 Appl Microbiol Biotechnol (2016) 100:7827–7839
product workup is omitted and reaction equilibria can be
shifted leading to an improved process efficiency and reduced
costs. In the field of HHDH catalysis, this cascade principle
has already been applied very early by combining HheC with
an epoxide hydrolase for the synthesis of optically active ha-
lohydrins, epoxides, and diols (Lutje Spelberg et al. 1999).
Since then, further enzymatic cascade reactions employing
HHDHs have been reported including the synthesis of
enantiopure β-azidoalcohols and β-hydroxynitriles starting
from prochiral α-chloroketones by combining an HHDHwith
(enantiocomplementary) alcohol dehydrogenases (ADHs;
Fig. 6) (Schrittwieser et al. 2009; Szymanski et al. 2010).
Recently, Chen et al. (2013) developed this concept further
by coexpressing all necessary enzymes (ADH, HHDH, and
cofactor-regenerating enzyme) in one bacterial host. By
adjusting expression levels of the different enzymes and opti-
mizing cofactor recycling, reaction times could be significant-
ly reduced while still reaching full conversion of the tested
chloroketones to the final products.
Zhu and coworkers reported a very efficient one-pot pro-
cess for the production of ethyl (R)-3-hydroxyglutarate from
ethyl (S)-4-chloro-3-hydroxybutyrate using recombinant
Escherichia coli whole cells (co)expressing an HheC mutant
and nitrilase AtNIT2 from Arabidopsis thaliana (Yao et al.
2015). This cascade involves three reaction steps starting with
the dehalogenation of ethyl (S)-4-chloro-3-hydroxybutyrate
and subsequent ring opening of the epoxide intermediate
using cyanide as the nucleophile catalyzed by the HHDH,
followed by hydrolysis of the introduced nitrile group cata-
lyzed by nitrilase AtNIT2. Using E. coli whole cells
coexpressing both genes, 600 mM ethyl (S)-4-chloro-3-
hydroxybutyrate was completely converted into ethyl (R)-3-
hydroxyglutarate within 6 h. As the nitrilase was inhibited by
ethyl (S)-4-chloro-3-hydroxybutyrate concentrations above
300 mM and NaCN concentrations above 200 mM, batch
feeding of the haloalcohol substrate as well as cyanide feeding
to control the pH of the reaction around pH 8–9 was applied.
Performing the HHDH and nitrilase reactions as one-pot, two-
step process—i.e., addition of nitrilase-expressing cells after
full conversion of ethyl (S)-4-chloro-3-hydroxybutyrate to
ethyl (R)-4-cyano-3-hydroxybutyrate— even allowed to run
the reaction at 1.2 M substrate concentration with complete
conversion within 12 h.
Spiroepoxides and oxazolidinones
Recently, HHDHs were shown to also convert spiroepoxides.
Azidolysis of different chiral and achiral spiroepoxides contain-
ing five- to seven-membered cycloalkane rings afforded the
corresponding β-azidoalcohols, carrying the OH group at the
tertiary carbon atom, in a highly regioselective fashion when
using HheA2 or HheC (Fig. 7; Majeric Elenkov et al. 2012).
This is in contrast to chemical azidolysis of spiroepoxides
which results in the formation of regioisomeric mixtures.
Using HheC, reactions of chiral spiroepoxide substrates even
proceeded with moderate to high enantioselectivity (E = 21–
200), whereas enantioselectivity of HheA2 was only low
(E ≤ 3). The obtained experimental results were further support-
ed by quantum-chemical calculations and docking simulations
explaining the regioselectivity and stereoselectivity of both
enzymes.
Previously, Majeric Elenkov et al. (2008) reported the syn-
thesis of enantiopure five-substituted oxazolidinones by
HheC-catalyzed kinetic resolution of different aliphatic epox-
ides. Epoxide ring opening with cyanate as nucleophile ini-
tially affords the corresponding isocyanate-cyanate species
which undergo rapid cyclization resulting in the formation of
2-oxazolidinones as final products (Fig. 8). This concept was
now extended to a dynamic kinetic resolution by in situ race-
mization of the slower reacting epoxide enantiomer through
reversible epoxide ring opening with bromide, also catalyzed
by HheC (Fig. 8; Mikleusevic et al. 2015). Thus, starting from
epibromohydrin and 2-bromomethyl-2-methyl-oxirane, the
corresponding (S)-configured oxazolidinones were obtained
in high yield (97 and 87 %, respectively) and high optical
purity (89 and >99 % ee, respectively) using only catalytic
amounts of NaBr. Especially, (S)-oxazolidinones are impor-
tant structural components of pharmaceuticals such as
oxazolidinone antibiotics (Barbachyn and Ford 2003) and
are important chiral auxiliaries and ligands in chemical syn-
thesis (Ager et al. 1996).
Assay developments
Over the years, different, usually spectrophotometric assays to
quantify HHDH activity have been reported in literature.
Initially, these assays have been developed to measure and
compare enzyme activity and kinetics of purified HHDHs in
a simple and fast way. Over the last decade, however, such
assays have become more and more important for HHDH
engineering to screen corresponding mutant libraries for new
variants with desired characteristics.
Ideally, measurements of product formation rates for typical
halohydrin dehalogenase reactions are commonly achieved by
direct quantification of educt or product concentrations using
chromatographic methods (GC, HPLC, etc.). While these
methods are highly accurate, they usually require sophisticated
equipment and/or can only process a limited number of samples
which generally contradicts the principle of (most) protein engi-
neering campaigns. In contrast, microtiter plate assays afford a
higher throughput and several protocols have been developed
for HHDH-catalyzed reactions. One of the earliest assays spe-
cifically adopted for HHDHs is the halide release assay
(Bergmann and Sanik 1957). This assay is based on the detec-
tion of halide ions released by HHDHs in the dehalogenation of
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halohydrins (Fig. 9; Schallmey et al. 2013). Although this assay
is specific, it requires the use of toxic chemicals such as mercury
thiocyanate. As an alternative, a pH-based assaywas reported by
Tang et al. (2010), making use of phenol red as pH indicator.
During HHDH-catalyzed halohydrin dehalogenation, protons
are released, resulting in acidification of a weakly buffered re-
action system and, thus, an absorbance change of the applied pH
indicator at 560 nm. This assay was used for high-throughput
screening of HHDH mutant libraries in microtiter-plate format
using whole cells. Both assays, however, can only be applied in
dehalogenation reactions, while HHDHs are also highly relevant
for the biocatalytic production ofβ-substituted alcohols through
epoxide ring opening. Hence, very recently, also two HHDH
assays have been developed for high-throughput screening of
HHDH mutant libraries in epoxide ring-opening reactions. The
first one, reported by Tang et al. (2015), is based on the adren-
aline test, which was previously already applied for activity
screening of other enzymes such as hydrolases or Baeyer-
Villiger monooxygenases (Kirschner and Bornscheuer 2008).
The assay principle is based on the oxidation of periodate-
sensitive compounds such as 1,2-diols or 1,2-aminoalcohols
with sodium periodate. Back titration of unreacted periodate
with L-adrenaline gives chromogenic adrenochrome which ab-
sorbs at 490 nm (Fig. 9). In case of HHDH catalysis, the assay
can be used for epoxide ring opening of α-hydroxylated epox-
ides such as glycidol, which results in the formation of a vicinal
diol upon ring opening with one of the accepted nucleophiles
(Tang et al. 2015). Alternatively, a 1,2-diol is also generated by
epoxide ring opening of any accepted epoxide substrate using
nitrite or formate as nucleophile, leading to unstable esters which
hydrolyze with formation of the corresponding diol (Fig. 1).
Hence, the adrenaline assay for HHDHs is rather restricted in
terms of epoxide substrates and nucleophiles that can be applied.
The other HHDH assay reported for epoxide ring opening
reactions was specifically developed for using azide as nucleo-
phile (Wan et al. 2015a). The assay is based on the quantification
of unreacted azide by adding FeCl3 solution, which results in
formation of a blood red Fe(III)/azide complex specifically ab-
sorbing at 460 nm— an assay principle already reported in 1932
(Labruto and Randisi 1932). Now, Wan et al. (2015a) adapted
and optimized this assay for the screening of a random muta-
genesis library in order to identify mutants of HheA3 from
P. lavamentivorans with improved activity in the conversion of
ethyl 4-chloro-3-hydroxybutyrate into ethyl 4-azido-3-
hydroxybutyrate.
Assaying the progress in cyanide-mediated epoxide ring
opening reactions is highly relevant for evolving carbon-
carbon bond forming activities in HHDHs. Recently, the spec-
trophotometric absorption at 267 nm of a specific cyanide-
Ni2+ complex was utilized to monitor cyanide consumption
in 96-well format during HHDH-catalyzed epoxide ring open-
ing (Schallmey et al. 2015).
Protein engineering
With proper assay protocols at hand, enzyme function can be
sculpted by means of protein engineering. Until recently, only
Fig. 8 Synthesis of chiral oxazolidinones by HHDH-catalyzed epoxide
ring opening with cyanate, a general reaction principle and b dynamic
kinetic resolution of racemic epibromohydrins for the production of the
corresponding (S)-oxazolidinones (Mikleusevic et al. 2015)
Fig. 6 Biocatalytic synthesis of chiral β-substituted alcohols by combination of a stereoselective alcohol dehydrogenase (ADH) and a halohydrin
dehalogenase (HHDH) (Schrittwieser et al. 2009)
Fig. 7 HHDH-catalyzed azidolysis of spiroepoxides (Majeric Elenkov
et al. 2012)
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five different HHDH sequences have been known. Hence, the
large majority of HHDH engineering campaigns has concen-
trated on only two different HHDHs, HheC and HheA2.
Especially structure-guided approaches have been exception-
ally successful in generating versatile HHDH variants. The
thorough, ProSAR-based study of Fox et al. (2007) started
from HheC wild-type and explored the accessible sequence
space for variants which could render the process from ethyl
(S)-4-chloro-3-hydroxybutyrate to ethyl (R)-4-cyano-3-
hydroxybutyrate economically viable. Here, more than
580,000 mutants were assessed by chromatographic methods
resulting in the identification of variants with at least 35 mu-
tations that matched the required process criteria. Variant
HheC-2360 —one of the enzymes originating from this
study— was later examined biochemically and structurally
(Schallmey et al. 2013). This HheC variant carries 37mutations
and displays a 3.1-fold increased kcat in the dehalogenation of
haloalcohol ethyl (S)-4-chloro-3-hydroxybutyrate, while an al-
most 10-fold increased kcat in the cyanolysis of the correspond-
ing epoxide ethyl (S)-3,4-epoxybutyrate is observed. At the
same time, enantiopreference of the variant for the haloalcohol
conversion was changed from R (ER = 4.8 for HheC) to S
(ES = 1.9 for HheC-2360). Structural analysis of enzyme
HheC-2360 revealed that few prominent changes of the enzyme
active site influenced the binding of target substrate compared to
wild-type HheC. Additionally, HheC-2360 exhibited an in-
creased thermal stability of at least 8 °C due to substantial in-
crease in buried surface area and enhanced interfacial interac-
tions between the monomers of the tetrameric assembly.
One limitation in the biocatalytic process for the synthesis
of ethyl (R)-4-cyano-3-hydroxybutyrate (Fig. 5) is the fact that
HheC is reversibly inhibited by the ketoreductase substrate
ethyl 4-chloroacetoacetate, thus hampering the development
of a true one-pot cascade reaction (Ma et al. 2010). The
inhibition was found to be the result of competitive binding
of ethyl 4-chloroacetoacetate in the active site of HheC with a
Ki of 0.249 μM (Chen et al. 2014). Subsequent saturation
mutagenesis of residues around the active site and the sub-
strate entrance tunnel resulted in the identification of mutant
F136V + W249F, which exhibited significantly less inhibi-
tion. Nevertheless, further protein engineering would be required
to generate a mutant suitable for application in a real cascade
process as mutant F136V + W249F displayed also threefold
lower activity toward ethyl 4-chloro-3-hydroxybutyrate com-
pared to wild-type HheC and still significant inhibition by ethyl
4-chloroacetoacetate.
Very recently, position T134 in HheC was reported to en-
hance epoxide cyanolysis rates of this HHDH (Schallmey
et al. 2015). By exchanging threonine 134 with alanine, a
mutant was obtained that displayed up to 11-fold improved
kcat values in the cyanolysis of various tested epoxides. At the
same time, this mutation also increased the dehalogenase ac-
tivity of HheC significantly, while enantioselectivity was gen-
erally reduced. Interestingly, Thr134 in HheC lies in close
proximity to Ser132 of the catalytic triad (Fig. 2d) and forms
a hydrogen bond with the side-chain O of Ser132. Hence,
mutation T134A does not directly influence nucleophile bind-
ing but rather alters the interaction between Ser132 and the
substrate oxygen due to the missing hydrogen bond.
Interestingly, other highly active HHDHs such as HheA3
and HheB and the majority of enzyme sequences generated
by Fox et al. (2007) (e.g., HheC-2360) also lack a hydrogen
bonding partner for the catalytic triad Ser.
The dehalogenase activity of HheC toward 1,3-
dichloropropanol could be also improved by mutagenesis of
the enzyme’s 10 C-terminal residues (Wang et al. 2015a). This
C-terminal overhang was chosen for site-saturation mutagen-
esis as it is only present in HheC and was shown to protrude
Fig. 9 HHDH assay principles, a
halide release assay for the
detection of released chloride and
bromide ions in the
dehalogenation of haloalcohols
(Iwasaki et al. 1952) and b
adrenaline assay for the detection
of vicinal diols formed in HHDH-
catalyzed epoxide ring opening
reactions (Tang et al. 2015)
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from one monomer of HheC into the active site of an opposing
monomer with effects on activity and selectivity (Tang et al.
2003). Complete truncation of this C-terminal overhang (res-
idues 246–254 in HheC) resulted in an overall lower thermo-
stability as well as drastically reduced activity. Single site-
saturation mutagenesis of these 10 residues revealed that ami-
no acid exchanges at positionW249 entailed a 2.7- to 4.3-fold
higher kcat value, while mutations at residues M252–E254
increased the enzyme’s thermostability (1.6- to 4.4-fold im-
proved thermal inactivation half-life at 55 °C). Afterwards,
combinatorial mutagenesis at positions W249 and M252-
E254 gave a mutant with combined improved activity and
thermostability. This resulted in the identification of a triple
mutant (HheC W249P + M252L + P253D) with almost 18-
fold increased thermal inactivation half-life and 4-fold im-
proved kcat compared to HheC wild-type. The significant in-
crease in thermostability was concluded to be the result of two
additional hydrogen bonds formed between D253 and E254.
In contrast, mutation W249P disrupts a hydrogen bond be-
tween W249 and Y187, which was suggested to stabilize the
conformation of the nucleophile binding pocket in HheC. In a
previous study by Tang et al. (2005), it was shown that muta-
tion Y187F also eliminated this hydrogen bond and resulted in
an enhanced halide release rate for the resulting mutant. Also
using 1,3-dichloropropanol as substrate, Tang and coworkers
identified a number of more active HheC mutants with muta-
tions at W139C (Tang et al. 2010) and W139V (Tang et al.
2013) later.
These authors also investigated the enantioselectivity of
HheA2 (Tang et al. 2012) and HheC (Guo et al. 2015) in the
dehalogenation of 2-chloro-1-phenylethanol by protein engi-
neering. While HheC wild-type preferentially converts the
(R)-enantiomer of this aromatic haloalcohol (with E = 65),
wild-type HheA2 displays a low (S)-selectivity. Saturation mu-
tagenesis of only three residues in HheA2 (V136, L141, and
N178) resulted in mutant HheA2 N178A exhibiting largely
increased (S)-selectivity (E > 200). In addition, double-mutant
HheA2 V136Y + L141G was identified, which displayed an
inverted enantioselectivity (ER = 13) due to a lower KM for (R)-
and higher KM for (S)-2-chloro-1-phenylethanol in comparison
to the parental enzyme (Tang et al. 2012). The three residues
were selected for mutagenesis after structural comparison of
HheA2 and HheC, in which residues V136, L141, and N178
of HheA2 were found in equivalent positions of residues T134,
W139, and N176 in HheC. The latter and four additional resi-
dues were also selected for iterative CASTing of HheC in order
to generate a more (R)-selective as well as an (S)-selective var-
iant (Guo et al. 2015). Two double mutants, HheC T134V +
L142M and HheC L142F + N176H, with improved (R)-selec-
tivity (E values of 104 and 132, respectively) toward 2-chloro-
1-phenylethanol were obtained. For both, higher (R)-selectivity
is caused by a reduced KM for the (R)-enantiomer, while KM for
(S)-2-chloro-1-phenylethanol was significantly increased
compared to wild-type HheC. The best (S)-selective mutant,
HheC P84V + F86P + T134A + N176A, exhibited an E value
of 101. Here too, the inverted enantioselectivity results from
altered binding affinities such as higher KM for (R)- and lower
KM for (S)-2-chloro-1-phenylethanol. At the same time, kcat
values toward both enantiomers changed significantly, resulting
in dramatically altered catalytic efficiencies. While HheC wild-
type displayed catalytic efficiencies of ~33,000 and
523 s−1 M−1 toward (R)- and (S)-2-chloro-1-phenylethanol, re-
spectively, the corresponding values for the best (S)-selective
variant were determined as 345 and ~36,000 s−1 M−1, respec-
tively. Interestingly, mutation N178A in HheA2 (equivalent to
position N176 in HheC) also conferred improved (S)-selectivity
(see above); however, mutation N176A alone did not result in
an (S)-selective HheC variant. Based on docking results and
MD simulations, the authors could also deduce the structural
basis for improved and/or inverted enantioselectivity in the
identified HheC mutants.
Protein engineering of HheC was also performed in a study
byXue et al. (2015b) to increase the enzyme’s enantioselectivity
in the synthesis of (S)-epichlorohydrin starting from prochiral
1,3-dichloropropanol. Upon single site-saturation mutagenesis
of several active-site residues, mutations P175S and W249P
were found to exert the desired effect. Combination of both
mutations resulted in a HheC variant which produced (S)-epi-
chlorohydrin in 95.3 % ee, while HheC wild-type gave only
5.2 % ee for the (S)-epoxide. Similarly, coworkers of Zheng
obtained a more active HheC mutant for the synthesis of epi-
chlorohydrin after introducing T134A and F186Y together with
12 other mutations in HheC (Liu et al. 2014).
Yohda and coworkers just published the first protein engi-
neering of HheB using a combination of site-directed and
random mutagenesis in order to increase its enantioselectivity
in the conversion of 1,3-dichloropropanol to (R)-4-chloro-3-
hydroxybutyronitrile via dehalogenation and subsequent
cyanolysis of the intermediate epichlorohydrin (Watanabe
et al. 2016). As a result, the triple mutant HheB F71W +
Q125T + D199H was identified giving the final product with
98.5 % ee.
Besides the improvement of enzyme characteristics such as
activity or selectivity, protein engineering can be also applied
to improve the expression of heterologous proteins. In this
respect, Tang et al. (2011) improved the heterologous expres-
sion of hheA2 in E. coli by saturating a GTG codon at position
+2. This way, variants with a CCC or CCA codon were iden-
tified displaying increased expression levels due to removal of
a stable mRNA secondary structure.
Conclusions
With the expansion of the HHDH enzyme family through
sequence motif-driven database mining, four new
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phylogenetic HHDH subtypes D through G could be defined,
with protein sequence identities between subtypes below
30 %. Although the initial biochemical and biocatalytic char-
acterization of 17 representative novel HHDHs did not reveal
any significantly new enzyme characteristics (Koopmeiners
et al. 2016), the more detailed investigation of additional
members of the ever growing HHDH enzyme family will
likely yield enzymes with novel features in the future. This
may eventually result in novel biocatalytic applications of
halohydrin dehalogenases beyond the current substrate and
product scopes.
So far, HheC still seems to be the only HHDH enzyme
exhibiting comparably high enantioselectivity in the conversion
of various substrates, whereas most other HHDHs are either
unselective or display only moderate enantioselectivity toward
a few selected substrates. With the help of protein engineering,
however, selectivity of halohydrin dehalogenases can be easily
tailored —also thanks to the availability of simple and fast
screening assays— and can thus be adapted to the respective
process requirements. Recent biocatalytic applications further
demonstrated that (wild-type) HHDHs can be employed in re-
actions using high substrate loadings—a prerequisite for indus-
trial processes— especially when applied as whole-cell
biocatalysts. This will facilitate their application in future bio-
transformations also at larger scale.
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